NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type
about
No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studiesThe dual roles of cytokines in Alzheimer's disease: update on interleukins, TNF-α, TGF-β and IFN-γDiverse molecular targets for therapeutic strategies in Alzheimer's diseaseTherapeutic potential of monoacylglycerol lipase inhibitorsNeuroinflammation in Alzheimer's disease; A source of heterogeneity and target for personalized therapyM1 and M2 immune activation in Parkinson's Disease: Foe and ally?Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapyNonsteroidal anti-inflammatory drugs are associated with increased neuritic plaquesCommonly prescribed drugs associate with cognitive function: a cross-sectional study in UK BiobankMitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration.Can peripheral leukocytes be used as Alzheimer's disease biomarkers?Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging.Aspirin for vascular dementia.Dementia and cognitive impairment: epidemiology, diagnosis, and treatment.Catalytic antioxidants and neurodegenerationIdentification of small molecule inhibitors of neurite loss induced by Aβ peptide using high content screening.Applied Healthspan engineering.Comparison between 3-Nitrooxyphenyl acetylsalicylate (NO-ASA) and O2-(acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (NONO-ASA) as safe anti-inflammatory, analgesic, antipyretic, antioxidant prodrugs.Function and comorbidities of apolipoprotein e in Alzheimer's disease.Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention.Rheumatoid arthritis-associated polymorphisms are not protective against Alzheimer's disease.Regular aspirin use does not reduce risk of cognitive declineEffects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial.Different mechanisms of apolipoprotein E isoform-dependent modulation of prostaglandin E2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia.Immune aging, dysmetabolism, and inflammation in neurological diseases.Elevated serum C-reactive protein relates to increased cerebral myoinositol levels in middle-aged adults.Neuroinflammatory Cytokines-The Common Thread in Alzheimer's PathogenesisA loss of function variant in CASP7 protects against Alzheimer's disease in homozygous APOE ε4 allele carriers.The impact of inflammation on cognitive function in older adults: implications for healthcare practice and researchRole of APOE and Age at Enrollment in the Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT).NSAID Use and Incident Cognitive Impairment in a Population-based Cohort.Histamine Induces Alzheimer's Disease-Like Blood Brain Barrier Breach and Local Cellular Responses in Mouse Brain Organotypic Cultures.Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype.Identification and modification of amyloid-independent phenotypes of APOE4 micePlasma signaling proteins in persons at genetic risk for Alzheimer disease: influence of APOE genotype.A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer's disease.Pharmacological Treatment of Alzheimer's Disease: Is it Progressing Adequately?Dementia prevention: methodological explanations for inconsistent results.Ginsenoside rg3 alleviates lipopolysaccharide-induced learning and memory impairments by anti-inflammatory activity in ratsSerum Abeta levels as predictors of conversion to mild cognitive impairment/Alzheimer disease in an ADAPT subcohort.
P2860
Q24642539-1B2732A2-CBC5-4D8D-939C-5E2BE9C3230CQ26750987-C3E98862-D017-43AA-AC35-1437822D9F81Q26827193-E7F5E193-29BB-4EEB-8900-A26E7BF68089Q26991513-A21CEAC2-CA7C-4B51-A780-039A21D3CE8BQ27014919-81BCE74A-6FC2-448E-AE8F-70378C117DEAQ27024667-21B1599B-1BA0-41A1-AABE-A8624F3D286EQ28282855-88364512-D3D9-4700-848D-DA4B9119D181Q28476681-6486509B-C49B-410F-91E4-6C300676EABAQ28586171-72AD2550-785E-4CA4-ACD1-76A958B36ED3Q33603263-D26D8EEE-54B4-4EE1-B2ED-69691BEFB844Q33689076-38C23912-A3A2-49F6-A542-9043E0D9BF6CQ33904501-AC75A7C0-DC26-4082-862F-7A77B8F591D6Q33909196-9C56819A-A730-4251-9537-C49FAFE8BB36Q33924014-609D1D0E-5AF1-4E65-9F6C-F34FE3B8F8FFQ34104938-B34AFB66-EF39-4B2F-9DE2-1DC75A11C3B9Q34141136-4A5597FE-0B8F-4219-91EE-F293BA98D132Q34157133-FC2879B4-0B46-4F8B-8EC1-EC3D1E819512Q34257599-A42B2DF3-8051-4927-B0F3-EFCAE26CA452Q34951817-ABB47F3D-DB75-4C52-ADE3-FB1FCCDB4B02Q34991223-C5C37347-D502-44D3-AEEE-A20F001B52FBQ35061264-BDADC449-6802-43F7-B94F-299CD4C58A89Q35117015-E13A2574-608F-4CAF-B200-B6F87A3B3328Q35523832-63CE39F7-35C5-42FE-933E-FA3DD0A1638EQ35555134-16F8C398-F3DB-43AC-8ADB-E2A092178AA0Q35677347-94770B64-6255-48D8-9B30-9BDC46DEC1BEQ35810862-9F421FE2-1ADA-4A7B-A5B6-A77955D1CC38Q35815212-66783D28-6358-4A4F-976E-6A2164A1DD5AQ36064459-780CA599-55FE-46BD-BA4B-A0CD57816595Q36079150-467C9777-0E97-400D-ABFC-6652E72B7375Q36213829-CDA214D7-1D18-4612-A740-3D85773B40C8Q36348370-84B44C36-04DC-4D4A-B357-C091AA255FC6Q36366819-D014D180-6C32-4AA1-B823-2E7DB4CC027DQ36457368-BD55222D-2AB5-4864-BF05-663B14042A2DQ36880457-D2A7A7C6-F753-406A-B861-BFA657E99B66Q36888445-3694B939-C239-4FA2-9972-D18268553C99Q37025979-CFEF0FF9-916C-4421-A8DB-E7C4F296F3D9Q37198579-813444AE-A940-443D-AF25-CDD16ECE6FF0Q37263684-2BD2C50C-2F45-4714-8B2F-F7E0AAC6AC4EQ37301199-A402D6FD-FC0B-4088-88A6-9E6F8530933CQ37314262-285F0B74-0876-44F4-9EE5-68201C953A19
P2860
NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
NSAID use and dementia risk in ...... y: role of APOE and NSAID type
@ast
NSAID use and dementia risk in ...... y: role of APOE and NSAID type
@en
type
label
NSAID use and dementia risk in ...... y: role of APOE and NSAID type
@ast
NSAID use and dementia risk in ...... y: role of APOE and NSAID type
@en
prefLabel
NSAID use and dementia risk in ...... y: role of APOE and NSAID type
@ast
NSAID use and dementia risk in ...... y: role of APOE and NSAID type
@en
P2093
P2860
P1433
P1476
NSAID use and dementia risk in ...... y: role of APOE and NSAID type
@en
P2093
A L Fitzpatrick
C A Szekely
J C S Breitner
L H Kuller
P2860
P356
10.1212/01.WNL.0000284596.95156.48
P407
P577
2007-11-14T00:00:00Z